The Motley Fool

Forget gold and Bitcoin! I’d buy these 2 cheap FTSE 100 shares to get rich and retire early

Image source: Getty Images

The FTSE 100’s market crash of 2020 could lead some investors to refocus their capital on assets such as gold and Bitcoin, rather than stocks. After all, gold and Bitcoin have outperformed the FTSE 100 over recent months, and could continue this trend in the short run.

However, the long-term track record of the FTSE 100 shows that it has always fully recovered from its downturns. As such, buying high-quality stocks while they are priced at low levels today could be a sound strategy.

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...

With that in mind, here are two FTSE 100 shares that could be worth buying today. They could boost your retirement prospects.

FTSE 100 housebuilder Taylor Wimpey

Housebuilder Taylor Wimpey’s (LSE: TW) recent trading update highlighted its financial strength during a challenging period for the wider industry. It has a cash position of around £836m, which suggests that it is in a strong position to overcome what could be an extended period of lower sales.

Demand for new homes may continue to be low over the coming months. With a challenging economic outlook, many prospective house purchasers may decide to postpone their decisions until there is greater clarity surrounding their employment situation. Therefore, even if construction restarts on Taylor Wimpey’s sites, demand for its homes could be weak for a while.

However, over the long run the FTSE 100 company may enjoy stronger operating conditions. The UK’s lack of housing supply, low interest rates and government schemes could sustain rising volumes of new homes in the coming years. As such, with Taylor Wimpey’s share price now trading 23% down on its level of the start of 2020, it could offer good value for money for long-term investors.

GSK

Another FTSE 100 share that could be worth buying today for the long run is GSK (LSE: GSK). Its recent update highlighted that assessing the financial impact of coronavirus in the current year is likely to be challenging. However, the company maintained its previous guidance after a strong first quarter that included an impressive growth rate across its portfolio.

GSK is set to experience a significant amount of change over the coming years. Its plans to divest consumer healthcare interests and shift its focus towards being a pharmaceutical business have continued. Yes, this process may cause some uncertainty in the short run. But it could lead to more focused operations that enable the separate entities to become more efficient.

With GSK recently confirming its quarterly dividend, it has a yield of around 4.7%. This suggests that it offers good value for money relative to many of its FTSE 100 index peers. It may also become more popular among income-seeking investors at a time when many large-cap shares are cutting their dividends. This could lead to strong total returns from the stock, which could boost your retirement prospects.

“This Stock Could Be Like Buying Amazon in 1997”

I'm sure you'll agree that's quite the statement from Motley Fool Co-Founder Tom Gardner.

But since our US analyst team first recommended shares in this unique tech stock back in 2016, the value has soared.

What's more, we firmly believe there's still plenty of upside in its future. In fact, even throughout the current coronavirus crisis, its performance has been beating Wall St expectations.

And right now, we're giving you a chance to discover exactly what has got our analysts all fired up about this niche industry phenomenon, in our FREE special report, A Top US Share From The Motley Fool.

Click here to claim your copy now — and we’ll tell you the name of this Top US Share… free of charge!

Peter Stephens owns shares of GlaxoSmithKline and Taylor Wimpey. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

The renowned analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply enter your email address below to discover how you can take advantage of this.

I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement.